Journal article · 2018 · Open access

Pancreatic Cancer: Recent Advances in Nanoformulation-Based Therapies

Preshita Prafulla Desai, David Kong Ann, Jeffrey Wang, Sunil V. Prabhu

Critical Reviews in Therapeutic Drug Carrier Systems, 36(1), 59–91 · Published 15 June 2018 · DOI 10.1615/critrevtherdrugcarriersyst.2018025459

Open full textView at the publisherCite this paper

In brief

“Pancreatic Cancer: Recent Advances in Nanoformulation-Based Therapies” is a 2018 journal article by Preshita Prafulla Desai and 3 co-authors, published in Critical Reviews in Therapeutic Drug Carrier Systems. OpenAlex counts 26 citations as of 21 November 2026. It is open access: the full text is free to read at PubMed Central.

Citations
26
Most cited in
2023 (7)
Field-weighted impact
0.63
References
102
Authors
4

Abstract

Pancreatic cancer is the fourth leading cause of death in the United States and has a 5-year life expectancy of ~8%. Currently, only a few drugs have been approved by the United States Food and Drug Administration for pancreatic cancer treatment. Despite available drug therapy and ongoing clinical investigations, the high prevalence and mortality associated with pancreatic cancer mean that there is an unmet chemopreventive and therapeutic need. From ongoing studies with various novel formulations, it is evident that the development of smart drug delivery systems will improve delivery of drug cargo to the pancreatic target site to ensure and enhance the therapeutic/chemoprevention efficacy of existing drugs and newly designed drugs in the future. With this in view, nanotechnology is emerging as a promising avenue to enhance drug delivery to the pancreas via both passive and active targeting mechanisms. Research in this field has grown extensively over the past decade, as is evident from available scientific literature. This review summarizes the recent advances that have brought nanotechnology-based formulations to the forefront of pancreatic cancer treatment.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Desai, P. P., Ann, D. K., Wang, J., & Prabhu, S. V. (2018). Pancreatic Cancer: Recent Advances in Nanoformulation-Based Therapies. Critical Reviews in Therapeutic Drug Carrier Systems, 36(1), 59–91. https://doi.org/10.1615/critrevtherdrugcarriersyst.2018025459

MLA 9

Desai, Preshita Prafulla, et al. “Pancreatic Cancer: Recent Advances in Nanoformulation-Based Therapies.” Critical Reviews in Therapeutic Drug Carrier Systems, vol. 36, no. 1, 2018, pp. 59–91. https://doi.org/10.1615/critrevtherdrugcarriersyst.2018025459.

Chicago

Desai, Preshita Prafulla, David Kong Ann, Jeffrey Wang, and Sunil V. Prabhu. 2018. “Pancreatic Cancer: Recent Advances in Nanoformulation-Based Therapies.” Critical Reviews in Therapeutic Drug Carrier Systems 36 (1): 59–91. https://doi.org/10.1615/critrevtherdrugcarriersyst.2018025459.

Harvard

Desai, P. P. et al. (2018) ‘Pancreatic Cancer: Recent Advances in Nanoformulation-Based Therapies’, Critical Reviews in Therapeutic Drug Carrier Systems, 36(1), pp. 59–91. doi:10.1615/critrevtherdrugcarriersyst.2018025459.

IEEE

P. P. Desai, D. K. Ann, J. Wang, and S. V. Prabhu, “Pancreatic Cancer: Recent Advances in Nanoformulation-Based Therapies,” Critical Reviews in Therapeutic Drug Carrier Systems, vol. 36, no. 1, pp. 59–91, 2018, doi: 10.1615/critrevtherdrugcarriersyst.2018025459.

BibTeX

@article{desai2018pancreatic,
  title     = {{Pancreatic Cancer: Recent Advances in Nanoformulation-Based Therapies}},
  author    = {Desai, Preshita Prafulla and Ann, David Kong and Wang, Jeffrey and Prabhu, Sunil V.},
  journal   = {Critical Reviews in Therapeutic Drug Carrier Systems},
  year      = {2018},
  volume    = {36},
  number    = {1},
  pages     = {59--91},
  doi       = {10.1615/critrevtherdrugcarriersyst.2018025459},
  url       = {https://doi.org/10.1615/critrevtherdrugcarriersyst.2018025459}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201933
202033
202133
202233
202377
202433
202533
202611

Its field-weighted citation impact is 0.63: it has been cited 0.63 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery

  • pancreatic cancer
  • nanotechnology
  • nanoformulations
  • drug delivery systems
  • targeted drug delivery
  • chemoprevention
  • active targeting
  • passive targeting

Work with this paper

Most-cited papers in Materials Science

All highly cited Materials Science papers

Questions about this paper

How do I cite this paper in APA style?

Desai, P. P., Ann, D. K., Wang, J., & Prabhu, S. V. (2018). Pancreatic Cancer: Recent Advances in Nanoformulation-Based Therapies. Critical Reviews in Therapeutic Drug Carrier Systems, 36(1), 59–91. https://doi.org/10.1615/critrevtherdrugcarriersyst.2018025459

How many times has this paper been cited?

26 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at PubMed Central: sign in and open the full text from this page.

Who wrote this paper?

Preshita Prafulla Desai, David Kong Ann, Jeffrey Wang, Sunil V. Prabhu.

What is the DOI of this paper?

10.1615/critrevtherdrugcarriersyst.2018025459, permanently at https://doi.org/10.1615/critrevtherdrugcarriersyst.2018025459. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.